Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

IP disputes in focus as TPP talks resume

Negotiators in Europe might still be preparing for the next round of transatlantic trade negotiations from the beach but those from countries on the Pacific Rim are already getting ready for a resumption in talks this week

Friday sees the start of the latest (the 19th in fact) round of talks for the Trans-Pacific Partnership (TPP) in Bandar Seri Begawan, Brunei. The country will play host to sherpas – the negotiators that do the heavy lifting before a deal is agreed – from the US, Australia, New Zealand, Chile, Peru, Brunei, Singapore, Malaysia, Vietnam, Canada, Mexico and Japan.

IP is already proving one of the hardest topics to resolve. That’s not surprising, given the gulf in economic development between, say, Vietnam on the one side and the US on the other.

TPP negotiators

The US government is understood to be pushing its trading partners to accept a range of so-called TRIPs-plus measures on IP, including patent term extensions and tougher rules on data exclusivity. It’s not just about pharmaceutical patents either. Negotiations continue to beef up regional rules on well-known trade marks, relax rules on what constitutes a trade mark and to give copyright owners more rights over their works.

So far, so what? The talks are simply rehashing old arguments about the level of protection countries should offer IP owners that have gone on since trade negotiators added IP to the table in the 1990s.

But what makes these talks different is the lengths to which negotiators are going to be seen to be open to all stakeholders. ACTA negotiators were stung (and ultimately beaten) by protestors angry about deals being conducted in secret and parliamentarians cross about being asked to rubber stamp agreements over which they had no control. Now many of the deal makers are trying to improve levels of transparency in the talks.

Of course some of this is window dressing. In the September issue of Managing IP we take a closer look at free trade deals and what they mean for IP owners and hear from stakeholders on both sides of the pharmaceutical patent divide. It still appears that big pharma has more direct access to their national negotiators than do groups that are sceptical about the expansion of IP rights.

But negotiators are providing more opportunities than ever for stakeholders to get involved. At the 16th round of TPP talks, for example, negotiations were adjourned for a day for meetings with some of the 300 stakeholders who were able to make it to Singapore. In Brunei a morning has been set aside for stakeholder presentations.

Such moves might not be enough to end complaints about secrecy and the close relationship between governments and big business. But they might help governments conclude an agreement that is more palatable to their electorates. As ACTA demonstrated, a one-sided deal can mean no deal at all.

more from across site and ros bottom lb

More from across our site

Lawyers wish the latest manual had more details on Federal Circuit cases and that training materials for design patent examiners were online
Counsel are eying domestic industry, concurrent PTAB proceedings and heightened scrutiny of cases before institution
Jack Daniel’s has a good chance of winning its dispute over dog toys, but SCOTUS will still want to protect free speech, predict sources
AI users and lawyers discuss why the rulebook for registering AI-generated content may create problems and needs further work
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
A technical effect must still be evident in the original patent filing, the EBoA said in its G2/21 decision today, March 23
Brands should not be deterred from pursuing lookalike producers, and an unfair advantage claim could be the key, say Emma Teichmann and Geoff Steward at Stobbs
Justice Mellor’s highly anticipated ruling surprised SEP owners and reassured implementers that the UK may not be so hostile after all
The England and Wales High Court's judgment comes ahead of a separate hearing concerning one of the patents-in-suit at the EPO
While the rules allow foreign firms to open local offices and offer IP services, a ban on litigation and practising Indian law could mean little will change